Skip to main content

MWG Biotech to Exit Microarray, Lab Automation

Click here for an updated version of this article.

NEW YORK, Oct. 8 (GenomeWeb News) - Ebersberg, Germany-based MWG Biotech today said that it plans to divest its microarray and lab automation businesses.

In a statement, the company said that managment will consider options for the divestiture of the product lines.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.